财经
Biotechs have begun breaking out, says Scott Colyer
Expanding earnings will keep driving biotech stocks higher, Advisor Asset Management's Scott Colyer tells Reuters' Fred Katayama.
财经
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up